Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis
Abstract Background Combination of statins and clopidogrel is frequently administered in patients with coronary artery disease (CAD). They are mainly activated and eliminated in the liver by cytochrome P450 isoenzyme 3A4 (CYP3A4). The aim was to clarify whether the coadministration of clopidogrel an...
Main Authors: | Ke An, Rong Huang, Sai Tian, Dan Guo, Jiaqi Wang, Hongyan Lin, Shaohua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-019-1053-0 |
Similar Items
-
Clopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet Aggregation
by: Shabnam Salimi, et al.
Published: (2016-10-01) -
Clopidogrel-statin interaction: A missing links
by: Todorović Zoran M., et al.
Published: (2016-01-01) -
The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01) -
In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
by: Rza Hajizadeh, et al.
Published: (2017-12-01) -
Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)